NSE: undefined BSE: undefined
₹-
(-%)
Sat, 04 Apr 2026, 00:32 am
Analysis
dividend
- Unable to evaluate Soni Medicare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Soni Medicare's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Soni Medicare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Soni Medicare has been profitable on average in the past, therefore cash runway is not a concern.
- Soni Medicare has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 1.2x debt.
- Soni Medicare's cash and other short term assets cover its long term commitments.
- Debt is not well covered by operating cash flow (11.3%, less than 20% of total debt).
- The level of debt compared to net worth has increased over the past 5 years (66.7% vs 93.9% today).
- Soni Medicare's level of debt (93.9%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- The tenure for the Soni Medicare board of directors is about average.
- Bimal's remuneration is lower than average for companies of similar size in India.
- Bimal's compensation has been consistent with company performance over the past year, both up more than 20%.
misc
- Soni Medicare is not covered by any analysts.
- BSE:539378 has not traded for 62 days.
past
- Unable to compare Soni Medicare's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Soni Medicare does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Soni Medicare has efficiently used its assets last year compared to the IN Healthcare industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Soni Medicare improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Soni Medicare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Soni Medicare's 1-year growth to the IN Healthcare industry average as it is not currently profitable.
value
- Soni Medicare's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Soni Medicare's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Soni Medicare is overvalued based on assets compared to the IN Healthcare industry average.
- Soni Medicare is loss making, we can't compare its value to the IN Healthcare industry average.
- Soni Medicare is loss making, we can't compare the value of its earnings to the India market.
- BSE:539378 is flat (0%) underperforming the Healthcare industry which returned 5.4% over the past month.
- BSE:539378 is flat (0%) underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800